| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |